KIDD BRIAN F 4
4 · NATIONAL HEALTHCARE CORP · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
NATIONAL HEALTHCARE (NHC) CFO Brian F. Kidd Exercises Options
What Happened
Brian F. Kidd, SVP and Chief Financial Officer of National Healthcare Corp (NHC), exercised stock options on March 4, 2026. He exercised 2,000 options at $53.94 (acquiring 2,000 shares for $107,880) and 4,000 options at $90.62 (acquiring 4,000 shares for $362,480), for a total cash exercise cost of $470,360. The company withheld 3,947 shares to satisfy the exercise price and withholding tax obligations (worth approximately $682,160). The underlying option positions (2,000 and 4,000-option grants) were converted/cancelled upon exercise.
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (period covered: 2026-03-04).
- Option exercises (code M): 2,000 shares @ $53.94 ($107,880) and 4,000 shares @ $90.62 ($362,480).
- Tax/exercise withholding (code F): 3,947 shares withheld @ $172.83 (~$682,160) to cover exercise price and taxes.
- The 2,000- and 4,000-share derivative disposals at $0.00 reflect the option conversion/cancellation upon exercise.
- Footnotes: options were granted under the 2020 Omnibus Equity Incentive Plan (grants dated Mar 8, 2023 and Feb 24, 2025) and are exempt from Section 16(b) under Rule 16b-3(d). Shares were withheld to pay exercise price and tax obligations (footnotes F1–F3).
- Shares beneficially owned after the transactions are reported on the filing (see footnote F4 on the Form 4).
Context
This was an option exercise with net/share-withheld settlement (company withheld shares to cover exercise cost and taxes), a common executive compensation action rather than an open-market buy or sell. Such exercises are typically routine and do not, by themselves, indicate a change in insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-03-04$53.94/sh+2,000$107,880→ 27,224 total - Exercise/Conversion
Common Stock
[F2]2026-03-04$90.62/sh+4,000$362,480→ 31,224 total - Tax Payment
Common Stock
[F3][F4]2026-03-04$172.83/sh−3,947$682,160→ 27,277 total - Exercise/Conversion
Option to Purchase Common Stock
[F1]2026-03-04−2,000→ 6,000 totalExercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (8,000 underlying) - Exercise/Conversion
Option to Purchase Common Stock
[F2]2026-03-04−4,000→ 9,500 totalExercise: $90.62From: 2026-02-24Exp: 2030-02-24→ Common Stock (13,500 underlying)
- 8,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (8,000 underlying) - 14,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (14,000 underlying)
Footnotes (4)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F3]Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
- [F4]Total amount of shares beneficially owned following transactions reported on this form.